Melbourne Australia: Starpharma Holdings Limited (ASX:SPL, OTCQX:SPHRY) invites you to listen to an audio broadcast with Chief Executive Officer Dr Jackie Fairley, regarding the successful results of the major phase 2 clinical study that demonstrated efficacy of VivaGel^® for the treatment of bacterial vaginosis (BV).

 The results of the trial were released to the ASX yesterday.

To listen to the Boardroom Radio audio broadcast please click on the following link, or copy and paste it into your browser:

 http://www.brr.com.au/event/81296